- Report
- January 2022
- 37 Pages
United States
- Report
- February 2019
- 150 Pages
North America
From €1338EUR$1,375USD£1,146GBP
€2676EUR$2,750USD£2,292GBP
- Report
- August 2022
- 30 Pages
Global
From €2676EUR$2,750USD£2,292GBP
- Report
- April 2023
- 120 Pages
Global
From €4622EUR$4,750USD£3,959GBP
- Report
- April 2023
- 112 Pages
Global
From €4622EUR$4,750USD£3,959GBP
- Report
- August 2019
- 110 Pages
Global
From €4816EUR$4,950USD£4,126GBP
- Report
- February 2023
- 198 Pages
Global
From €7297EUR$7,500USD£6,251GBP
- Report
- January 2022
- 200 Pages
Global
From €7297EUR$7,500USD£6,251GBP
- Report
- January 2022
- 60 Pages
Global
From €3843EUR$3,950USD£3,292GBP
- Report
- July 2020
- 143 Pages
Global
From €6762EUR$6,950USD£5,793GBP
- Report
- August 2022
- 115 Pages
Global
From €4378EUR$4,500USD£3,751GBP
- Drug Pipelines
- July 2019
- 345 Pages
Global
€21406EUR$22,000USD£18,337GBP
- Clinical Trials
- May 2020
- 878 Pages
Global
From €2432EUR$2,500USD£2,084GBP
- Report
- February 2022
- 36 Pages
Global
From €1946EUR$2,000USD£1,667GBP
- Drug Pipelines
- July 2020
- 63 Pages
Global
From €1946EUR$2,000USD£1,667GBP
- Drug Pipelines
- June 2020
- 81 Pages
Global
From €1946EUR$2,000USD£1,667GBP
- Report
- June 2023
- 25 Pages
Japan
From €825EUR$908USD£731GBP
- Report
- August 2021
- 21 Pages
United States
- Report
- January 2024
- 84 Pages
Global
From €3500EUR$3,853USD£3,103GBP
- Report
- May 2023
- 96 Pages
Global
From €3500EUR$3,853USD£3,103GBP
Cannabidiol (CBD) is a cannabinoid found in the Cannabis sativa plant. It is a non-psychoactive compound that has been studied for its potential therapeutic effects on the central nervous system (CNS). CBD has been found to have anti-inflammatory, antioxidant, and neuroprotective properties, and has been studied for its potential to treat a variety of neurological disorders, including epilepsy, anxiety, depression, and Parkinson's disease.
CBD is increasingly being used as an alternative to traditional CNS drugs, such as benzodiazepines and opioids. It is being studied for its potential to reduce the side effects of traditional medications, as well as its potential to treat a variety of neurological conditions.
The CBD market is growing rapidly, with a variety of products available, including oils, tinctures, edibles, and topical creams. Companies in the market include Charlotte's Web, Elixinol, and Endoca. Show Less Read more